Navigation Links
Study: Benefit to women not enough to sway men to get HPV vaccine
Date:6/2/2009

TALLAHASSEE, Fla. -- Informing men that a new vaccine to prevent human papillomavirus (HPV) would also help protect their female partners against developing cervical cancer from the sexually transmitted infection did not increase their interest in getting the vaccine, according to a new Florida State University study.

Mary Gerend, assistant professor of medical humanities and social sciences at the FSU College of Medicine, and Jessica Barley, a 2008 Florida State psychology graduate who based her honors thesis on the study, found that men are no more likely to want the vaccination just because they can help protect their female sexual partners. An HPV vaccine for women has been available since 2006, and a vaccine for men is likely to be approved in the near future.

"You can probably interpret this finding in a number of ways," Gerend said. "Thinking about the benefit to their own health -- protection again rare genital cancers and genital warts -- is all men really need to know; telling them all that extra stuff really isn't going to push them one way or another."

For maximum benefit to public health, both men and women should be vaccinated but little was known about men's interest in the vaccine before Gerend's study, which was published in the journal Sexually Transmitted Diseases. Gerend presented the findings recently at the annual meeting of the Society of Behavioral Medicine in Montreal.

HPV is the most common sexually transmitted infection, according to the Centers for Disease Control and Prevention (CDC), which estimates that approximately 20 million Americans are currently infected with HPV and that another 6.2 million people become newly infected each year. HPV-related cancers are very rare in men, but last year the American Cancer Society estimated that nearly 20,000 women would be diagnosed with cervical and other cancers caused by HPV in 2008.

Gerend's research team randomly divided 356 male colle
'/>"/>

Contact: Doug Carlson
doug.carlson@med.fsu.edu
850-645-1255
Florida State University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. U of M study: Early treatment can reverse heart damage
2. New study: Pine bark reduces perimenopausal symptoms
3. U of M study: Health food supplement may curb addiction of pathological gamblers
4. New study: Pine bark extract reduces ADHD symptoms in children
5. Kaiser Permanente study: Alcohol amount, not type -- wine, beer, liquor -- triggers breast cancer
6. UGA study: Youth exposed to smokeless tobacco ads despite settlement
7. New National Medicaid Study: Minnesota Under Funds Seniors Nursing Home Care $167 Million Annually
8. Study: Modafinil is effective in treating excessive sleepiness
9. Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume
10. New study: pine bark extract boosts nitric oxide production
11. Study: HPV test beats Pap in detecting cervical cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009).... 20 Following a recall by Unileve...from sale Shedd,s Country Crock ® Side Dishes...Crock ® Side Dishes DELUXE Four Cheese Pasta ...following code dates and UPCs are affected: ,, ...heddar Broccoli Rice 21 oz, UPC 027400218316, Best...
(Date:11/20/2009)...PRNewswire-USNewswire/ -- The American Dental Asso...dministration (FDA) to establish appropriate class...iting concern about the safety of whitening produc... of professional consultation or examination by a ... of chemically based tooth whitening or bleaching ...
(Date:11/20/2009)...., Nov. 20 Samuel Gladd...ine what it means to be "happy" during the holiday...cialty in family counseling and chair of the Depar...dding says research shows that it is the pressure ...epression during the holidays. ,, That,s why he...
(Date:11/20/2009)...ne November 20 in the Journal of the National Can... hopes that often appear in news coverage of cance...th the media and journals to help alleviate the pr...n Woloshin, M.D., M.S., of Center for Medicine and...olicy and Clinical Practice in New Hampshire, and ...
(Date:11/20/2009)...ber 20, 2009Emergency medical service (EMS) provid...00 cardiac arrests each year. Only 5 to 10 percen.... Better quality cardiopulmonary resuscitation (C...ssociated with better patient outcome. The Resusc...linical research network to study prehospital trea...
Breaking Medicine News(10 mins):Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...ch 5 Peregrine Pharmaceuticals, Inc. (Nasdaq: P...ancial results for the third quarter of fiscal yea... host a conference call and webcast to discuss the... 2009 and will review recent operating highlights....
...eives EU and US Approvals for Intravenous Formulat...l Temozolomide Sachet Presentation , , KENILWORTH...: SGP ) today announced that the European Commis...emozolomide is marketed as TEMODAL(R) in the EU an...
... Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) tod...l year 2008 financial results after the NASDAQ Glo...at same afternoon, Jack Lief, Arena,s President an.... Eastern Time (2:00 p.m. Pacific Time) to discuss...
...., March 5 Smith & Nephew Inc,s Advanced Woun...y announced the U.S. launch of its next Negative P...SYS (TM) GO, designed to address the needs of cli...wound care. The U.S. Food and Drug Administration ...
...acquisition of NMHC drives GAAP earnings per share...4 2008, up from $6.5 million in Q4, 2007, ,...C Health Solutions Corp. ("SXC" or the "Company") ... in U.S. dollars unless otherwise indicated. , "20...
...e demand for a reliable, non-invasive, efficient a...s, lifestyles is boosting interest in bone growth ...t is however still small, as clinicians have felt ... research papers to substantiate the efficacy of t...
Other Medicine News:Health News:Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results 2Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 2Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 3Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 4Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 5Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 6Health News:European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors 7Health News:Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009 2Health News:Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009 3Health News:Smith & Nephew Introduces RENASYS(TM) GO, Portable NPWT for Mobile, Active Patients 2Health News:Smith & Nephew Introduces RENASYS(TM) GO, Portable NPWT for Mobile, Active Patients 3Health News:Smith & Nephew Introduces RENASYS(TM) GO, Portable NPWT for Mobile, Active Patients 4Health News:Smith & Nephew Introduces RENASYS(TM) GO, Portable NPWT for Mobile, Active Patients 5Health News:SXC Health solutions announces strong fourth quarter and year end financial results 2Health News:SXC Health solutions announces strong fourth quarter and year end financial results 3Health News:SXC Health solutions announces strong fourth quarter and year end financial results 4Health News:SXC Health solutions announces strong fourth quarter and year end financial results 5Health News:SXC Health solutions announces strong fourth quarter and year end financial results 6Health News:SXC Health solutions announces strong fourth quarter and year end financial results 7Health News:SXC Health solutions announces strong fourth quarter and year end financial results 8Health News:SXC Health solutions announces strong fourth quarter and year end financial results 9Health News:SXC Health solutions announces strong fourth quarter and year end financial results 10Health News:SXC Health solutions announces strong fourth quarter and year end financial results 11Health News:SXC Health solutions announces strong fourth quarter and year end financial results 12Health News:SXC Health solutions announces strong fourth quarter and year end financial results 13Health News:SXC Health solutions announces strong fourth quarter and year end financial results 14Health News:SXC Health solutions announces strong fourth quarter and year end financial results 15Health News:SXC Health solutions announces strong fourth quarter and year end financial results 16Health News:SXC Health solutions announces strong fourth quarter and year end financial results 17Health News:SXC Health solutions announces strong fourth quarter and year end financial results 18Health News:SXC Health solutions announces strong fourth quarter and year end financial results 19Health News:SXC Health solutions announces strong fourth quarter and year end financial results 20Health News:According to Frost & Sullivan, Mounting Clinical Evidence Underlines Benefits of Bone Growth and Spinal Fusion Stimulators 2Health News:According to Frost & Sullivan, Mounting Clinical Evidence Underlines Benefits of Bone Growth and Spinal Fusion Stimulators 3
(Date:11/20/2009)...swire/ -- ,, Reportlinker.com announces that a ...alogue. ,, Global Markets for Breast Biopsy De...164741/Global-Markets-for-Breast-Biopsy-Devices-20...p;utm_campaign=prnewswire ,, The global marke...oaded core needle market and vacuum assisted breas...
(Date:11/20/2009)...re-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX )...ef Executive Officer, and Greg Browne, Chief Finan...r Jaffray Health Care Conference in New York on We...nference session and webcast will be audio only an...ay will host a webcast of the presentation live an...
(Date:11/19/2009)...ewswire/ -- Warner Chilcott plc (Nasdaq: WCRX ) t...nced secondary offering of 20,000,000 of its ordin...share. The selling shareholders include funds aff...anking, J.P. Morgan Partners (advised by CCMP Capi...er institutional investors and members of the Comp...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4NHLBI awards 2411 million for molecular roadmap to chronic lung diseases 10289 1NHLBI awards 2411 million for molecular roadmap to chronic lung diseases 10289 2Long Term Back Pain Not Inevitable Study Finds 59075 1Long Term Back Pain Not Inevitable Study Finds 59075 2Endovenous Laser Therapy Used for Treatment of Varicose Veins 59071 1Endovenous Laser Therapy Used for Treatment of Varicose Veins 59071 2
...onference Call on Monday, April 14, at 8:30 a.m. E...m.com , CARLSBAD, Calif., April 14 Isis,Pharmace...l results from its,ongoing Phase 2 open-label exte...amilial hypercholesterolemia (FH). In FH patients ...e safety profile of the drug,continues to be encou...
...3 Researchers from the,Barbara Ann Karmanos Cance...owing that adding curcumin or resveratrol to conve...ing the growth of chemo-resistant colon cancer,cel...merican Association,for Cancer Research (AACR) Ann...om.com/cgi-bin/prnh/20071106/KARMANOSCANCERINSTITU...
Other Medicine Technology:Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 2Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 3Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 4Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 5Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 6Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells 2
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: